Study of Matrix Metalloproteinase (MMP)-9 expressions in ocular surface disorders using dry eye diagnostic kit InflammaDry

Study of Matrix Metalloproteinase (MMP)-9 expressions in ocular surface disorders using dry eye diagnostic kit InflammaDry - Study of MMP-9 expressions in ocular surface disorders using InflammaDry

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014423

Enrollment

Registered

2014-07-01

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious keratitis, non-infectious corneal ulcer, Sjogren syndrome, meibomian gland dysfunction, etc.

Interventions

The case is tested only once, at the first visit.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who are over 20 years-old. 2) Patients who have ocular surface disorders mentioned previously. 3) Patients who are visiting the clinic 4) Patients who are able to obtain informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients who may have the possibility to have contagious diseases. 2) Patients who are considered to be unsuitable for various reasons.

Design outcomes

Primary

Measure	Time frame
Detection of MMP-9 using InflammaDry	—

Secondary

Measure	Time frame
Findings of slitlamp microscopy in each cases	—

Countries

Japan

Contacts

Public ContactTohru Sakimoto

Nihon University School of Medicine Ophthalmology

torusaki@gmail.com03-3972-8111(2531)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026